Our latest Investing Matters Podcast episode with QuotedData's Edward Marten has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRMDL.L Regulatory News (RMDL)

  • There is currently no data for RMDL

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Amendment to the Investment Management Agreement

12 May 2020 13:49

RNS Number : 6698M
RM Secured Direct Lending PLC
12 May 2020
 

12 May 2020

RM Secured Direct Lending PLC

("RMDL" or the "Company")

AMENDMENT TO THE INVESTMENT MANAGEMENT AGREEMENT

Revised ongoing fee schedule and further alignment to investor interests

RMDL, the closed-ended investment trust established to invest in a portfolio of secured debt instruments, announces that the Investment Management Agreement (the "IMA"), dated 30 November 2016, between the Company, RM Capital Markets Limited (the "Investment Manager") and International Fund Management Limited (the "AIFM") has been amended.

Following the amendment to the IMA, the Investment Manager is entitled to a management fee (the "Management Fee") calculated at the rate of:

a) 0.875 per cent. of the prevailing Net Asset Value ("NAV") in the event that the prevailing NAV is up to or equal to £250 million; or

b) 0.800 per cent. of the prevailing NAV in the event that the prevailing NAV is above £250 million but less than £500 million; or

c) 0.750 per cent. of the prevailing NAV in the event that the prevailing NAV is above £500 million.

This compares to a previous management fee calculated at the rate of 0.875 per cent. of the prevailing NAV, or in the event that the prevailing NAV was less than £75 million, the Investment Manager was entitled to a management fee calculated at the rate of 0.50 per cent. per annum of the prevailing NAV.

In addition, the term of the IMA has been extended. Initially the IMA was subject to 12 months' notice, provided such notice could not be given earlier than the third anniversary of the initial admission of RMDL's shares to trading on the London Stock Exchange's main market for listed securities which took place on 15 December 2016. Following the amendment of the IMA, the appointment of the Investment Manager is subject to 12 months' notice provided such notice cannot be given earlier than 1 April 2023.

The IMA now also provides that the Investment Manager must apply up to 10 per cent. of the Management Fee received quarterly (subject to a minimum of £10,000 being so applied) subscribing and/or purchasing shares in RMDL. The obligation of the Investment Manager in this regard shall be satisfied on a quarterly basis starting in Q2 2020.

Norman Crighton, Chairman, said: "On behalf of the Board, I am pleased to announce this amendment and extension to the IMA with RM Funds. We have a strong belief in RMDL's investment proposition and RM Funds' management given its successful track record of delivery. These changes to the IMA will reduce the ongoing charges for Shareholders as the portfolio Net Asset Value grows while RM Funds' commitment to continue to purchase shares further aligns its interests with Shareholders. We look forward to continuing this successful partnership and offering investors access to stable, long term, above average returns."

James Robson, Chief Investment Officer, commented: "We thank the Board for their continued support. We welcome this further continued alignment with investor interests as we look to increase the RM Funds shareholding of RMDL in excess of the 1,200,000 shares currently owned and look forward to being of continued service to the Company."

 

 

 

END

 

 For further information, please contact:

RM Capital Markets Limited - Investment Manager

James Robson

Pietro Nicholls

Tel: 0131 603 7060

 

Nplus1 Singer Advisory LLP - Financial Adviser and Broker

James Maxwell

Carlo Spingardi

Tel: 020 7496 3000

 

Tulchan Group - Financial PR

Elizabeth Snow

Deborah Roney

Tel: 0207 353 4200

 

PraxisIFM Fund Services (UK) Limited - Administrator and Company Secretary

Brian Smith

Ciara McKillop

Tel: 020 7653 9690

 

 

 

 

About RM Secured Direct Lending

 

RM Secured Direct Lending Plc ("RMDL" or the "Company") is a closed-ended investment trust established to invest in a portfolio of secured debt instruments.

 

The Company aims to generate attractive and regular dividends through loans sourced or originated by the Investment Manager with a degree of inflation protection through index-linked returns where appropriate. Loans in which the Company invests are predominantly secured against assets such as real estate or plant and machinery and/or income streams such as account receivables.

 

For more information, please see

https://rmdl.co.uk/investor-centre/monthly-factsheets/

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCGPUQCAUPUGPP
Date   Source Headline
20th Jul 20215:29 pmRNSHolding(s) in Company
16th Jul 20212:31 pmRNSInvestment Manager's Holding
16th Jul 20217:00 amRNSNet Asset Value(s)
15th Jul 20219:30 amRNSHolding(s) in Company
9th Jul 20217:00 amRNSIrrevocable Share Repurchase Programme
16th Jun 20217:00 amRNSNet Asset Value(s)
8th Jun 20214:22 pmRNSResult of AGM
26th May 20217:00 amRNSDividend Declaration
17th May 20217:00 amRNSNet Asset Value(s)
12th May 20217:00 amRNSRefreshed investment focus & Company name change
19th Apr 20214:37 pmRNSInvestment Manager's Holding
16th Apr 20215:46 pmRNSHolding(s) in Company
16th Apr 20217:00 amRNSNet Asset Value(s)
6th Apr 202111:17 amRNSResult of General Meeting
29th Mar 20217:00 amRNSFinal Results
29th Mar 20217:00 amRNSUpdate on ZDP Shares and New Loan Facility
29th Mar 20217:00 amRNSFinal Results
17th Mar 20217:00 amRNSInvestor Webinar
16th Mar 20217:00 amRNSNet Asset Value(s)
25th Feb 20217:00 amRNSDividend Declaration
25th Feb 20217:00 amRNSTransaction in Own Shares & Total Voting Rights
23rd Feb 20219:52 amRNSIrrevocable Share Repurchase Programme
18th Feb 20217:00 amRNSTransaction in Own Shares & Total Voting Rights
16th Feb 20217:00 amRNSNet Asset Value(s)
29th Jan 20217:00 amRNSTransaction in Own Shares & Total Voting Rights
28th Jan 20217:00 amRNSTransaction in Own Shares & Total Voting Rights
25th Jan 20217:00 amRNSAdditional allocation under CBILS
22nd Jan 20217:00 amRNSTransaction in Own Shares
22nd Jan 20217:00 amRNSInvestment Manager's Holding
15th Jan 20217:00 amRNSNet Asset Value(s)
5th Jan 20217:00 amRNSTransaction in Own Shares & Total Voting Rights
31st Dec 20207:00 amRNSTransaction in Own Shares
22nd Dec 20205:08 pmRNSHolding(s) in Company
18th Dec 20205:43 pmRNSHolding(s) in Company
18th Dec 20207:00 amRNSTransaction in Own Shares & Total Voting Rights
17th Dec 20207:01 amRNSDividend reclassification
17th Dec 20207:00 amRNSNet Asset Value(s)
24th Nov 20207:00 amRNSTransaction in Own Shares & Total Voting Rights
16th Nov 20207:00 amRNSNet Asset Value(s)
9th Nov 20207:00 amRNSTransaction in Own Shares & Total Voting Rights
2nd Nov 20202:39 pmRNSDividend Declaration
29th Oct 20207:00 amRNSTransaction in Own Shares & Total Voting Rights
28th Oct 20207:00 amRNSTransaction in Own Shares
21st Oct 20207:00 amRNSInvestment Manager's Holding
16th Oct 20207:00 amRNSNet Asset Value(s)
16th Oct 20207:00 amRNSTransaction in Own Shares
12th Oct 202011:29 amRNSDirector Declaration
9th Oct 20204:27 pmRNSTransaction in Own Shares
8th Oct 20207:00 amRNSTransaction in Own Shares & Total Voting Rights
5th Oct 20207:00 amRNSTransaction in Own Shares & Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.